Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

131.26
Delayed Data
As of Jul 02
 +5.07 / +4.02%
Today’s Change
84.41
Today|||52-Week Range
137.50
+10.49%
Year-to-Date

Today’s Trading

Previous close126.19
Today’s open127.02
Day’s range126.00 - 132.00
Volume3,660,501
Average volume (3 months)1,469,305
Market cap$30.1B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+43.00%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book27.77

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-1.38-0.75%
MYLMylan NV+0.42+0.60%
ZTSZoetis Inc-0.12-0.25%
BMRNBiomarin Pharmaceuti...+0.11+0.08%
Data as of 4:14pm ET, 07/02/2015

Financials

Next reporting dateJuly 27, 2015
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers